Delivery Order SPE2DB24D2205-SPE2DB25FDXKB

Award Date 1/27/25
Potential Completion Date 1/28/25
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,367.20 firm fixed-price delivery order is for the supply of Lyrica 100 mg capsules. The contract has an ultimate completion date of February 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,615.71 firm-fixed-price delivery order is for the supply of Lyrica 200 mg capsules with an ultimate completion date of October 31, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $2,151.60 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA). The contract is for the delivery of Lyrica 150 mg capsules and has a completion date of November 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,534.92 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract provides a range of pharmaceutical products, including LYRICA 225 MG CAPSULE 90S, to support military healthcare programs. The award has an ultimate completion date of January 7, 2025 and a firm fixed price pricing structure. The contract was not set...
This federal contract award, valued at $13,961.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for 4,567,117,597 units of the pharmaceutical product Lyrica 50 mg Capsules, with a completion date of February 3, 2025. The contract has a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,672.05 firm fixed-price delivery order is for the supply of Lyrica 50 mg capsules, a medication used to treat nerve pain. The contract has an ultimate completion date of December 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order, valued at $2,743.17, is for the supply of Lyrica 75 mg capsules. The contract has an ultimate completion date of April 24, 2024 and is a firm fixed-price delivery order. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The $10,758.00 delivery order is for the provision of Lyrica 150 mg capsules, a prescription medication. The contract has a firm fixed price pricing type and an ultimate completion date of July 12, 2024. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order issued under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract valued at $999,999,999. The contract covers the supply of a wide range of pharmaceutical products, medical supplies, and equipment to support military healthcare programs globally. The specific award is for Lyrica 100 mg capsules, with a ceiling value of $2,985.88 and a period of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,693.70 firm fixed price delivery order is for the supply of Lyrica 50 mg capsules. It is part of a larger indefinite delivery contract (IDC) with DLA that has a potential value of $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDXKB
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,546.96 firm fixed-price delivery order is for the supply of Lyrica 50 mg capsules. The contract has an ultimate completion date of January 28, 2025.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/4/25, 12:46 AM